Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Efficacy of Different Treatment Regimens for Early Missed Abortion
NCT07422506Recruiting
- Sponsor
- Third Xiangya Hospital, Central South University
- Start
- Jan 2024
- Primary completion
- Jan 2030
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Open-label trial of estradiol valerate in missed abortion (4 arms), sponsored by Third Xiangya Hospital, Central South University. Primary endpoints: Number of Participants with Complete Abortion Following Treatment at 14 days and Number of Participants with Intrauterine Adhesions (IUA) at 3 months. Started Jan 2024; status: recruiting.
02
Drugs
estradiol valerate
03
Conditions
missed abortion
Beyond the preview
Go deeper on NCT07422506.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07422506.